|
Media Releases |
Financial Reports |
Presen-tations |
|
08.02.2002
|
|
|
|
| Basel - Lonza announced today that a company sponsored clinical study conducted at Ball State University (Indiana, USA), has found that L-Carnitine L-Tartrate supplementation significantly helps weekend warriors during their recovery from high intensity exercise. Weekend warriors or recreational athletes typically experience soreness and stiffness in exercised muscles following an extended lay-off from exercise. |
Clinical Study Finds Recovery in "Weekend Warriors" is Enhanced by Supplementation with Lonza's L-Carnitine L-Tartrate
|
 |
Dr. William Kraemer, Principal Investigator for the study points out that "a speedy and less painful recovery is important for all people who exercise, be it regularly or irregularly, as recovery affects how quickly a person can return to exercising optimally."
L-Carnitine is a vitamin-like nutrient which is essential for turning fat into energy in the human body. Due to previous clinical findings, L-Carnitine is a popular supplement among physically active people who supplement with L-Carnitine to help improve their performance, while simultaneously delaying the onset of fatigue. Extensive research has discovered that L-Carnitine has cardioprotective properties and studies also indicate that L-Carnitine is useful as part of a weight management program.
The present clinical study used a balanced, placebo-controlled, cross-over design in which ten healthy active men took either placebo or L-CARNIPURE® L-Carnitine L-Tartrate (equivalent to 2 g L-Carnitine) for 3 weeks, prior to a controlled exercise session. "We are extremely excited by the results of the study which indicate that L-Carnitine L-Tartrate supplementation, prior to high intensity exercise, is effective in assisting recovery, allowing for less tissue damage, decreased production of free radicals and significantly less muscle soreness following the exercise," said Dr. Kraemer.
Dr. Andrea O. Schaffhauser, Manager Scientific Affairs & Market Development, Lonza Ltd., commented, 'We are pleased to be presenting this breakthrough data to the scientific committee.'
Lonza Group is the world's largest manufacturer of L-Carnitine and is the only manufacturer that guarantees 100% pure L-Carnitine, completely free from harmful D-Carnitine. The L-CARNIPURE® logo is a sign of this quality assurance. L-Carnitine L-Tartrate (US Patent 5,073,376 and other international patents) is the most popular form of L-Carnitine in the market. This white, crystalline, non-hygroscopic product contains 68% L-Carnitine and 32% natural L-Tartaric acid. L-Carnitine L-Tartrate is manufactured according to cGMP standards for bulk pharmaceuticals and is kosher certified. Further details are available at www.carnitine.com.
Lonza Group is a Life Sciences company headquartered in Switzerland, with sales of CHF 1.87 billion in 2001 and operating 13 facilities in 6 countries. It employs 4900 people worldwide and is the leading supplier of active chemical ingredients, intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries. It also offers a broad catalogue of organic intermediates for a wide range of applications such as pharmaceuticals, agrochemicals, vitamins, food and feedstuff, dyes and pigments, adhesives and fragrances. Furthermore the Group manufactures specialty biocides and oleochemicals.
For further information please contact:
Dr. Walter Eschenmoser
Communications
Tel +41 61 316 8363
Fax +41 61 316 8220
walter.eschenmoser@lonzagroup.com
Dr. Andrea O. Schaffhauser
Manager Scientific Affairs/Market Dev.
Lonza Ltd
Tel +41 61 316 85 47
Fax +41 61 316 84 46
andrea.schaffhauser@lonzagroup.com
|
|
|
